| 000 | 01710cam a2200313 a 4500 | ||
|---|---|---|---|
| 003 | EG-GiCUC | ||
| 005 | 20250223031747.0 | ||
| 008 | 170729s2014 ua f m 000 0 eng d | ||
| 040 |
_aEG-GiCUC _beng _cEG-GiCUC |
||
| 041 | 0 | _aeng | |
| 049 | _aGift | ||
| 097 | _aM.Sc | ||
| 099 | _aCai01.34.M.Sc.2014.Sa.N | ||
| 100 | 0 | _aSamy Abdalla Mehany Habib | |
| 245 | 1 | 0 |
_aN{u2160}-linked metatonin dimers as bivalent ligands targeting dimeric melatonin receptors / _cSamy Abdalla Mehany Habib ; Supervsied Darius P. Zlotos |
| 246 | 1 | 5 | _aكمركبات ثنائية التكافؤ تستهدف مستقبلات الميلاتونين المثنوية N{u2160}- مركبات ميلاتونين ثنائية الوحدات مرتبطة عن طريق |
| 260 |
_aCairo : _bSamy Abdalla Mehany Habib , _c2014 |
||
| 300 |
_a118 Leaves ; _c30cm |
||
| 502 | _aThesis (M.Sc.) - German University - Faculty of Postgraduate Studies and Scientific Research - Department of Pharmaceulical Chemistry | ||
| 520 | _aThe diverse physiological actions of the pineal neurohormone melatonin are mainly mediated through activation of two G-protein-coupled receptors MT₁, and MT₂. These receptors are known to form homo-and heterodimers with distinct functions and properties opening new perspectives for drug design and drug treatment. The bivalent ligand approach is a common strategy for targeting dimeric GPCRs | ||
| 653 | 4 | _aDimeric melatonin receptors | |
| 653 | 4 | _aN{u2160}-linked metatonin dimers | |
| 653 | 4 | _aTargeting dimeric GPCRs | |
| 700 | 0 |
_aDarius P. Zlotos , _eSupervisor |
|
| 856 | _uhttp://172.23.153.220/th.pdf | ||
| 905 |
_aNazla _eRevisor |
||
| 905 |
_aSamia _eCataloger |
||
| 942 |
_2ddc _cTH |
||
| 999 |
_c61690 _d61690 |
||